1. Recombinant chicken interleukin-7 as a potent adjuvant increases the immunogenicity and protection of inactivated infectious bursal disease vaccine.
- Author
-
Cui D, Zhang J, Zuo Y, Huo S, Zhang Y, Wang L, Li X, and Zhong F
- Subjects
- Adjuvants, Immunologic administration & dosage, Animals, Birnaviridae Infections immunology, Birnaviridae Infections prevention & control, Escherichia coli genetics, Interleukin-7 administration & dosage, Poultry Diseases immunology, Random Allocation, Recombinant Proteins genetics, Recombinant Proteins immunology, Vaccines, DNA administration & dosage, Vaccines, DNA immunology, Vaccines, Inactivated administration & dosage, Vaccines, Inactivated immunology, Viral Vaccines administration & dosage, Birnaviridae Infections veterinary, Chickens, Immunogenicity, Vaccine, Infectious bursal disease virus immunology, Interleukin-7 immunology, Poultry Diseases prevention & control, Viral Vaccines immunology
- Abstract
Our previous work showed that a plasmid-based chicken interleukin-7 (chIL-7) gene expression vector possessed potent adjuvant activity for a VP2 DNA vaccine against chicken infectious bursal disease virus (IBDV). Whether recombinant chIL-7 prepared in procaryotic expression system has the adjuvant activity for inactivated IBDV vaccine remains unknown. Here, we prepared recombinant chIL-7 using an E. coli expression system and analyzed its adjuvant activity for the inactivated IBDV vaccine. The results show that the recombinant chIL-7 was successfully prepared in E. coli using the pET20b vector, which possessed biological activity to stimulate mouse B lymphocyte proliferation. Co-administration of the chIL-7 with inactivated IBDV vaccine significantly increased specific serum antibody titers against IBDV, enhanced lymphocyte proliferation and IFN-γ and IL-4 productions, and increased protection against virulent IBDV infection.
- Published
- 2018
- Full Text
- View/download PDF